<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03237910</url>
  </required_header>
  <id_info>
    <org_study_id>IRFMN-7167-7429</org_study_id>
    <nct_id>NCT03237910</nct_id>
  </id_info>
  <brief_title>Real Time Amplitude Spectrum Area to Guide Defibrillation</brief_title>
  <acronym>AMSA</acronym>
  <official_title>AMplitude Spectrum Area to Guide Defibrillation During Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mario Negri Institute for Pharmacological Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zoll Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mario Negri Institute for Pharmacological Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      AMSA trial is a multicenter, randomized, controlled study in out-of-hospital cardiac arrest
      patients.

      The purpose of the study is to test the hypothesis that a real time AMSA analysis during CPR
      may predict the success of defibrillation and optimize the timing of defibrillation delivery.

      The primary end-point is the efficacy of the AMSA-CPR: termination of VF/VT with achievement
      of ROSC for an AMSA ≥ 15.5 mV-Hz

      All patients meeting inclusion/exclusion criteria and receiving cardiopulmonary resuscitation
      are randomized into two groups: AMSA-guided CPR or standard CPR.

      In the AMSA-CPR group, AMSA value suggests when the rescuer should deliver the defibrillation
      attempt; In the Standard-CPR group, the defibrillation is delivered based on the 2015
      European Resuscitation Council (ERC) CPR guidelines.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the AMSA-CPR intervention, upon arrival of the advanced life support (ALS) rescue team at
      the cardiac arrest scene and application of the defibrillatory pads to the patient's chest
      and power on of the defibrillator with the real time AMSA analysis:

        -  If AMSA is ≥ 15.5 mV-Hz, an immediate defibrillation is attempted, followed by CPR

        -  If AMSA is &lt; 15.5 mV-Hz, defibrillation is not attempted and CPR is delivered

        -  During the 2-min cycle of CPR, AMSA is measured during pauses for ventilations (every 30
           CC, approximately every 20/25 sec). If an AMSA value ≥ 15.5 mV-Hz is achieved prior to
           cycle completion, an immediate defibrillation is delivered (thus the defibrillation
           attempt is anticipated)

      After completion of the first 2-min CPR cycle:

        -  If AMSA is ≤ 6.5 mV-Hz, the defibrillation is not attempted but CPR is continued

        -  If AMSA is &gt; 6.5 mV-Hz, an immediate defibrillation attempt is delivered, followed by
           CPR

        -  During the 2-min cycle of CPR, AMSA is measured during pauses for ventilations (every 30
           CC, approximately every 20/25 sec). If an AMSA value ≥ 15.5 mV-Hz is achieved prior to
           cycle completion, an immediate defibrillation is delivered

      After completion of the second 2-min CPR cycle and till the end of the resuscitative
      intervention:

      • CPR is continued based on standard 2015 ERC guidelines (a defibrillation attempt every
      2-min CPR cycles), except for the possibility to anticipate the defibrillation attempt if
      AMSA becomes ≥ 15.5 mV-Hz during the CPR cycle.

      In the standard CPR intervention, upon arrival of the ALS team at the cardiac arrest scene,
      and application of the defibrillatory pads to the patient's chest and power on of the
      defibrillator:

      • a defibrillation is immediately attempted and CPR is then started and continued for 2- min.
      Analysis of rhythm and subsequent defibrillation attempts are performed every 2-min CPR
      cycles.

      In both study groups, the quality of CC and ventilation is monitored in real time thought the
      feedback integrated into the defibrillator.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Return of spontaneous circulation (ROSC)</measure>
    <time_frame>At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)</time_frame>
    <description>Termination of ventricular fibrillation with achievement of ROSC for an AMSA value ≥ 15.5 mV-Hz</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Defibrillation attempts</measure>
    <time_frame>At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)</time_frame>
    <description>Number of defibrillations to achieve ROSC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPR duration</measure>
    <time_frame>At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)</time_frame>
    <description>duration of CPR in minutes prior to achieve ROSC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac troponins</measure>
    <time_frame>at 6 and 24 hours after ICU admission</time_frame>
    <description>assessment of circulating levels of high sensitive cardiac troponin T in plasma as marker of cardiac injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short term survival</measure>
    <time_frame>at hospital admission and 24 hours after ROSC</time_frame>
    <description>number of patients alive after initial resuscitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term survival</measure>
    <time_frame>at 1 and 6 months after ROSC</time_frame>
    <description>number of patients alive after initial resuscitation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">398</enrollment>
  <condition>Out-Of-Hospital Cardiac Arrest</condition>
  <condition>Ventricular Fibrillation</condition>
  <arm_group>
    <arm_group_label>AMSA-CPR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The professional rescuer decides to deliver the defibrillation attempt based on the AMSA value displayed in the defibrillator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard-CPR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The defibrillation is delivered based on the 2015 European Resuscitation Council CPR guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>AMSA</intervention_name>
    <description>A non-invasive and real time VF (Amplitude Spectrum Area) AMSA analysis is performed during chest compression pauses for delivery of 2 ventilations, from the ECG acquired from the conventional defibrillatory pads</description>
    <arm_group_label>AMSA-CPR</arm_group_label>
    <other_name>VF waveform analysis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Defibrillation</intervention_name>
    <description>delivery of the defibrillation is attempted to terminate VF either based on AMSA value (in the AMSA-CPR arm) or every 2-min CPR cycle as recommended by current guidelines (in the Standard-CPR arm)</description>
    <arm_group_label>AMSA-CPR</arm_group_label>
    <arm_group_label>Standard-CPR</arm_group_label>
    <other_name>electric countershock</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CPR</intervention_name>
    <description>chest compressions and ventilations at a rate of 30:2</description>
    <arm_group_label>AMSA-CPR</arm_group_label>
    <arm_group_label>Standard-CPR</arm_group_label>
    <other_name>resuscitation maneuvres</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All adult patients (age ≥ 18) suffering of out-of-hospital non traumatic cardiac arrest of
        presumably cardiac etiology with a presenting shockable rhythm requiring electrical
        defibrillation: Ventricular Fibrillation and pulseless Ventricular Tachycardia.

        Exclusion Criteria:

          -  age &lt; 18 years old

          -  pregnancy

          -  cardiac arrest with a non-shockable rhythm (pulseless electrical activity and
             asystole)

          -  a defibrillation delivered by an AED prior to ALS arrival

          -  cardiac arrest of traumatic origin

          -  non-cardiac cause of cardiac arrest

          -  presumable irreversible death or known terminal illness at the beginning of ALS

          -  clinical death

          -  participation in another clinical or device trial within the previous 30 days

          -  refused informed consent to the use of data.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Ristagno, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Istituto Di Ricerche Farmacologiche Mario Negri</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roberto Latini, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Istituto Di Ricerche Farmacologiche Mario Negri</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe Ristagno, MD, PhD</last_name>
    <phone>3299738490</phone>
    <phone_ext>4613</phone_ext>
    <email>gristag@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Francesca Fumagalli, MSc</last_name>
    <phone>023901</phone>
    <phone_ext>4622</phone_ext>
    <email>francesca.fumagalli@marionegri.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UOC Rianimazione-Emergenza Territoriale 118, Dipartimento di Emergenza, Ospedale Maggiore - AUSL di Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Federico Semeraro, MD</last_name>
      <phone>051 4132009</phone>
      <email>fsemeraro2008@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Giovanni Gordini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SOREU Metropolitana - AREU ASST, Grande Ospedale Metropolitano Niguarda</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giovanni Sesana, MD</last_name>
      <phone>0264443356</phone>
      <email>aatmi@areu.lombardia.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Sesana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SSD 118, Dipartimento di Medicina Perioperatoria Terapia Intensiva ed Emergenza. Azienda Sanitaria Universitaria Integrata di Trieste</name>
      <address>
        <city>Trieste</city>
        <zip>34128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Umberto Lucangelo, MD</last_name>
      <phone>040 3995090</phone>
      <email>u.lucangelo@fmc.units.it</email>
    </contact>
    <investigator>
      <last_name>Alberto Peratoner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://cordis.europa.eu/project/rcn/207233_en.html</url>
    <description>EU Framework Horizon 2020 Programme under grant agreement no. 733381: European Sudden Cardiac Arrest network: towards Prevention, Education and New Treatment (ESCAPE-NET)</description>
  </link>
  <link>
    <url>https://www.erc.edu/projects/escape-net</url>
    <description>ESCAPE NET in ERC website</description>
  </link>
  <link>
    <url>https://www.escardio.org/Sub-specialty-communities/European-Heart-Rhythm-Association-(EHRA)/Research/escape-net</url>
    <description>ESCAPE NET in EHRA website</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2017</study_first_submitted>
  <study_first_submitted_qc>July 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2017</study_first_posted>
  <last_update_submitted>January 22, 2018</last_update_submitted>
  <last_update_submitted_qc>January 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>amplitude spectrum area</keyword>
  <keyword>defibrillation</keyword>
  <keyword>waveform analysis</keyword>
  <keyword>cardiopulmonary resuscitation</keyword>
  <keyword>cardiac arrest</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

